Heart disease is still the number one killer in the U.S.—but are we even looking at the right markers to prevent it? In this eye-opening episode, Shana sits down with Dr. Urban Kiernan, founder and CEO of iMetabolic Biopharma Corporation, to break down what your lipid panel actually means, why total cholesterol and LDL often distract from the real risks, and how insulin resistance plays a central role in heart disease—especially during menopause. Dr. Kiernan shares how his biotech company is leveraging AI, protein therapy, and root-cause science to transform how we prevent and treat metabolic disease—and why most conventional approaches miss the mark entirely. If you've ever been confused by your labs, put on statins without a full explanation, or wondered why we're still seeing record rates of heart attacks and strokes, this conversation will bring clarity and direction. 🔑 What You'll Learn: The truth about cholesterol testing: which markers matter and which don't Why LDL-C alone is a poor predictor of heart disease risk How to quickly assess insulin resistance from standard labs The real drivers of the heart disease epidemic Why risk spikes during menopause—and what you can do about it How personalized, precision medicine could change the future of prevention About Dr. Urban Kiernan: Dr. Kiernan is the founder and CEO of iMetabolic Biopharma Corporation (iMBP), a precision biotherapeutics company creating AI-driven therapies that target the root causes of metabolic and cardiovascular diseases. His work blends science, biotechnology, and deep personal mission after losing his wife to cancer—driving his pursuit of true root-cause solutions. 🔗 Links Mentioned: 🌐 Learn about iMetabolic Biopharma Corporation ✨ Explore the Feel Great System 🧪 Shana's Courses & Coaching Programs 🎧 More Episodes of the Optimal Metabolism Podcast

Ver todos los episodios